BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login
search help

Search Results

Documents 1-25 out of 186 found
  Current Search:  anthrax: 186     

HTML
100%
Emergent BioSolutions to Webcast Presentation at the 6th Annual Southwestern Showcase Investor Conference on N
- Emergent BioSolutions Inc.

(NYSE:EBS) announced today that the company will be webcasting its presentation at the 6 th Annual Southwestern Showcase Investor Conference scheduled for Thursday, November 20, 2008 at 1:40 pm Central.

A...

Pharma Live:  Nov 19 2008 9:55PM
Matching: anthrax
Find similar documents
HTML
100%
PharmAthene signs deal with Israeli firm to market biodefense drugs
PharmAthene Inc.

has signed a deal with Medison Pharma Ltd.

to commercialize its biodefense drugs in Israel.

Medison, based in Petach Tikva, Israel, gets an exclusive license to shepherd drugs from Annapolis-based PharmAthenes pipeline...

Baltimore Business Journal:  Nov 19 2008 9:28PM
Matching: anthrax
Find similar documents
HTML
100%
University of Central Florida
4000 Central Florida Boulevard Orlando Florida 32816 U.S.A.

Phone: 407-823-2000 Fax: Industry Company News Two New Compounds Show Promise For Eliminating Breast Cancer Tumors, Study 11/19/2008 7:19:13 AM More...

University of Central...

BioSpace:  Nov 19 2008 6:52PM
Matching: anthrax
Find similar documents
HTML
100%
PharmAthene signs deal with Israeli firm to market biodefense drugs
Medison, based in Petach Tikva, Israel, gets an exclusive license to shepherd drugs from Annapolis-based PharmAthenes pipeline to that countrys commercial marketplace everything from gaining regulatory approval to overseeing marketing and...
East Bay Business Journal:  Nov 19 2008 7:52PM
Matching: anthrax
Find similar documents
HTML
100%
Enigma Diagnostics Launches Field Laboratory (FL) System, Fully Automated Real-Time PCR for In-Field Testing
PORTON DOWN, England, Nov.

18 /PRNewswire/ -- Enigma Diagnostics, the decentralised and point-of-care molecular diagnostics company, announces the launch of its upgraded version of Enigma FL at the XIth International CBRN Defence Symposium...

Clinical Lab Products:  Nov 18 2008 5:44PM
Matching: anthrax
Find similar documents
HTML
100%
Noble, Inc. Entertainment Security & BioDefense Corp. Strike Alliance
Noble, Inc.

Entertainment Security (http://www.nobleincsecurity.com), one of the largest and most-respected full-service professional security agencies nationwide, has signed an exclusive alliance with BioDefense Corporation (http://www...

Genetic Engineering News:  Nov 17 2008 9:17PM
Matching: anthrax
Find similar documents
HTML
100%
Disaster planning should be priority for hospital pharmacists, experts say
Disasters should be defined broadly The past decade has featured devastating hurricanes, floods, fires, and terrorist acts that have captured headlines often for weeks at a time.

What the nation's heightened awareness of disasters has...

Pharmacy Choice:  Nov 15 2008 5:09PM
Matching: anthrax
Find similar documents
HTML
100%
Emergent BioSolutions Files Universal Shelf Registration Statement
ROCKVILLE, Md.-- (BUSINESS WIRE) -- Emergent BioSolutions Inc.

(NYSE:EBS) announced today that it has filed with the U.S.

Securities and Exchange Commission (SEC) a universal shelf registration statement which, when declared effective,...

SmartBrief:  Nov 14 2008 1:41AM
Matching: anthrax
Find similar documents
HTML
100%
Pharmathene Reports Third Quarter 2008 Financial and Operational Results
ANNAPOLIS, Md., Nov.

13 /PRNewswire-FirstCall/ -- PharmAthene, Inc.

, a biodefense company developing medical countermeasures against biological and chemical threats, today reported financial and operational results for the third quarter...

Montana's News Station:  Nov 14 2008 2:44PM
Matching: anthrax
Find similar documents
HTML
100%
Pharmathene Reports Third Quarter 2008 Financial and Operational Results
ANNAPOLIS, Md., Nov.

13 /PRNewswire-FirstCall/ -- PharmAthene, Inc.

, a biodefense company developing medical countermeasures against biological and chemical threats, today reported financial and operational results for the third quarter...

KRON4:  Nov 14 2008 2:13PM
Matching: anthrax
Find similar documents
HTML
100%
Pharmathene Reports Third Quarter 2008 Financial and Operational Results
ANNAPOLIS, Md., Nov.

13 /PRNewswire-FirstCall/ -- PharmAthene, Inc.

, a biodefense company developing medical countermeasures against biological and chemical threats, today reported financial and operational results for the third quarter...

KOTA Territory News:  Nov 14 2008 3:18AM
Matching: anthrax
Find similar documents
HTML
100%
Pharmathene Reports Third Quarter 2008 Financial and Operational Results
ANNAPOLIS, Md., Nov.

13 /PRNewswire-FirstCall/ -- PharmAthene, Inc.

, a biodefense company developing medical countermeasures against biological and chemical threats, today reported financial and operational results for the third quarter...

KLFY:  Nov 14 2008 2:33AM
Matching: anthrax
Find similar documents
HTML
100%
Pharmathene Reports Third Quarter 2008 Financial and Operational Results
ANNAPOLIS, Md., Nov.

13 /PRNewswire-FirstCall/ -- PharmAthene, Inc.

, a biodefense company developing medical countermeasures against biological and chemical threats, today reported financial and operational results for the third quarter...

KSLA:  Nov 14 2008 12:21AM
Matching: anthrax
Find similar documents
HTML
100%
Emergent BioSolutions Files Universal Shelf Registration Statement
- Emergent BioSolutions Inc.

(NYSE:EBS) announced today that it has filed with the U.S.

Securities and Exchange Commission (SEC) a universal shelf registration statement which, when declared effective, will permit the company to issue up...

Pharma Live:  Nov 13 2008 1:52PM
Matching: anthrax
Find similar documents
HTML
100%
Response Biomedical Corporation Announces Third Quarter Results
VANCOUVER, Nov.

13 /PRNewswire-FirstCall/ - Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) reported that it recorded total revenues of $1,471,130 and a net loss of $3,648,602 or ($0.03) per share for the three month period ended...

Forbes.com:  Nov 13 2008 2:19PM
Matching: anthrax
Find similar documents
HTML
100%
Response Biomedical Corporation Announces Third Quarter Results
Company Reports Record Revenues - Increasing Product Sales Trend Expected to Continue VANCOUVER, Nov.

13 /PRNewswire-FirstCall/ - Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) reported that it recorded total revenues of $1,471...

San Francisco Business Times:  Nov 13 2008 1:49PM
Matching: anthrax
Find similar documents
HTML
100%
Response Biomedical Corporation Announces Third Quarter Results
Company Reports Record Revenues - Increasing Product Sales Trend Expected to Continue VANCOUVER, Nov.

13 /PRNewswire-FirstCall/ - Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) reported that it recorded total revenues of $1,471...

Cincinnati Business Journal:  Nov 13 2008 1:39PM
Matching: anthrax
Find similar documents
HTML
100%
Response Biomedical Corporation Announces Third Quarter Results
Company Reports Record Revenues - Increasing Product Sales Trend Expected to Continue VANCOUVER, Nov.

13 /PRNewswire-FirstCall/ - Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) reported that it recorded total revenues of $1,471...

San Antonio Business Journal:  Nov 13 2008 1:36PM
Matching: anthrax
Find similar documents
HTML
100%
Response Biomedical Corporation Announces Third Quarter Results
Company Reports Record Revenues - Increasing Product Sales Trend Expected to Continue VANCOUVER, Nov.

13 /PRNewswire-FirstCall/ - Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) reported that it recorded total revenues of $1,471...

Nashville Business Journal:  Nov 13 2008 1:35PM
Matching: anthrax
Find similar documents
HTML
100%
Response Biomedical Corporation Announces Third Quarter Results
Company Reports Record Revenues - Increasing Product Sales Trend Expected to Continue VANCOUVER, Nov.

13 /PRNewswire-FirstCall/ - Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) reported that it recorded total revenues of $1,471...

The Business Journal Phoenix:  Nov 13 2008 1:29PM
Matching: anthrax
Find similar documents
HTML
100%
Aradigm Announces Third Quarter 2008 Financial Results
Aradigm Corporation (OTCBB:ARDM) (the 'Company') today announced financial results for the third quarter and nine months ended September 30, 2008.

Revenue for the third quarter was $197,000, compared with revenue of $230,000 for the third...

Red Orbit:  Nov 13 2008 3:13AM
Matching: anthrax
Find similar documents
HTML
100%
Some Stocks At 52 Week High-AFAM,EBS,CBST
Symbols: AFAM, CBST, EBS Author Alerts by Email We never spam!

Related RSS Feeds AFAM Headline Feed CBST Headline Feed EBS Headline Feed All Symbols Sector Feeds: Buoyed by China stimulus plan, US stocks opened with strong gains!

However...

I Stock Analyst:  Nov 11 2008 2:40AM
Matching: anthrax
Find similar documents
HTML
100%
Aradigm Completes Study of Inhaled Treprostinil with AERx(R) Inhaler
HAYWARD, Calif.-- (BUSINESS WIRE) -- Aradigm Corporation (OTCBB:ARDM) Data from the study showed that the AERx Essence inhaler efficiently delivered aerosolized treprostinil deeper into the lung than delivery by the OPTINEB nebulizer.
SmartBrief:  Nov 11 2008 6:50PM
Matching: anthrax
Find similar documents
HTML
100%
Human Genome Sciences Announces Third Quarter 2008 Financial Results and Key Developments
ROCKVILLE, Md., Nov.

6 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc.

(Nasdaq: HGSI) today announced financial results and key developments for the quarter ended September 30, 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh...

Rehab Manegement:  Nov 10 2008 3:44AM
Matching: anthrax
Find similar documents
HTML
100%
Aradigm Completes Study of Inhaled Treprostinil with AERx(R) Inhaler
- Aradigm Corporation (OTCBB:ARDM) Data from the study showed that the AERx Essence inhaler efficiently delivered aerosolized treprostinil deeper into the lung than delivery by the OPTINEB nebulizer.

Inhaled treprostinil was well tolerated...

DiGiTAL50:  Nov 10 2008 7:08PM
Matching: anthrax
Find similar documents

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997- - BioPortfolio Limited.